KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Charles River Laboratories International (CRL) Long-Term Debt Issuances (2016 - 2025)

Charles River Laboratories International has reported Long-Term Debt Issuances over the past 16 years, most recently at $156.7 million for Q4 2025.

  • Quarterly results put Long-Term Debt Issuances at $156.7 million for Q4 2025, up 49.5% from a year ago — trailing twelve months through Dec 2025 was $1.2 billion (up 13.49% YoY), and the annual figure for FY2025 was $1.2 billion, up 13.49%.
  • Long-Term Debt Issuances for Q4 2025 was $156.7 million at Charles River Laboratories International, up from $107.5 million in the prior quarter.
  • Over the last five years, Long-Term Debt Issuances for CRL hit a ceiling of $3.0 billion in Q2 2021 and a floor of $51.2 million in Q3 2023.
  • Median Long-Term Debt Issuances over the past 5 years was $428.3 million (2024), compared with a mean of $649.5 million.
  • Biggest five-year swings in Long-Term Debt Issuances: soared 111972800.0% in 2021 and later tumbled 92.67% in 2023.
  • Charles River Laboratories International's Long-Term Debt Issuances stood at $831.4 million in 2021, then plummeted by 81.51% to $153.8 million in 2022, then surged by 188.31% to $443.3 million in 2023, then tumbled by 76.36% to $104.8 million in 2024, then skyrocketed by 49.5% to $156.7 million in 2025.
  • The last three reported values for Long-Term Debt Issuances were $156.7 million (Q4 2025), $107.5 million (Q3 2025), and $547.0 million (Q2 2025) per Business Quant data.